J. Christopher Naftzger Arbutus Biopharma Corp (ABUS) insider trading activity

J. Christopher Naftzger is General Counsel and CCO of Arbutus Biopharma Corp. Currently has a direct ownership of 140,544 shares of ABUS, which is worth approximately $465,200. The most recent transaction as insider was on Feb 14, 2025, when has been sold 54,300 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 141K

47.79% 3M change

47.79% 12M change

Total Value Held $465,200

J. Christopher Naftzger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2025	BUY Grant, award, or other acquisition	-	54,300 Added 27.87%	140,544 Common Shares
Feb 04 2025	SELL Open market or private sale	$37,172 $3.28 p/Share	11,333 Reduced 11.61%	86,244 Common Shares
Feb 01 2024	BUY Grant, award, or other acquisition	-	95,100 Added 50.0%	95,100 Common Shares

Also insider at

NBRV

Nabriva Therapeutics plc Healthcare

General Counsel and Corp Sec

JCN